Status:
COMPLETED
Sildenafil Citrate and Recurrent Abortion
Lead Sponsor:
Benha University
Conditions:
Recurrent Abortion
Eligibility:
FEMALE
20-35 years
Phase:
NA
Brief Summary
Two groups of unexplained recurrent spontaneous abortion, each included 65 participants. scheduled randomly into; the study group received Sildenafil Citrate and Placebo group. The intervention starte...
Detailed Description
Two groups of unexplained recurrent spontaneous abortion, each included 65 participants. scheduled randomly into; the study group received Sildenafil Citrate and Placebo group. The intervention starte...
Eligibility Criteria
Inclusion
- Unexplained recurrent spontaneous abortion.
Exclusion
- Abnormal uterine cavity.
- Luteal phase insufficiency.
- Endocrinal disorders, e.g., thyroid diseases, hyperprolactinemia, and Diabetes Mellitus.
- Antiphospholipid syndrome.
- Inherited or acquired thrombophilia.
- Patients had renal, hepatic or cardiovascular diseases, hypertension, history of smoking, treated with vasodilators or sensitive to or developed severe side-effects with Sildenafil Citrate.
Key Trial Info
Start Date :
December 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2017
Estimated Enrollment :
130 Patients enrolled
Trial Details
Trial ID
NCT03475160
Start Date
December 1 2015
End Date
December 1 2017
Last Update
March 23 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.